Center for HIV/AIDS Vaccine Immunology and Immunogen Discovery (UM1)

The summary for the Center for HIV/AIDS Vaccine Immunology and Immunogen Discovery (UM1) grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.

Center for HIV/AIDS Vaccine Immunology and Immunogen Discovery (UM1): This FOA, issued by the National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health, solicits grant applications that propose to establish a Center for HIV/AIDS Vaccine Immunology and Immunogen Discovery (CHAVI-ID) to support a coordinated, multidisciplinary team of researchers focused on multi-pronged approaches to accelerate HIV vaccine development by addressing key immunological roadblocks to the discovery and development of a safe and effective HIV vaccine.

Federal Grant Title:	Center for HIV/AIDS Vaccine Immunology and Immunogen Discovery (UM1)
Federal Agency Name:	National Institutes of Health
Grant Categories:	Health
Type of Opportunity:	Discretionary
Funding Opportunity Number:	RFA-AI-11-002
Type of Funding:	Cooperative Agreement
CFDA Numbers:	93.855
CFDA Descriptions:	Allergy, Immunology and Transplantation Research
Current Application Deadline:	Sep 08, 2011
Original Application Deadline:	Sep 08, 2011
Posted Date:	Mar 29, 2011
Creation Date:	Mar 29, 2011
Archive Date:	Oct 09, 2011
Total Program Funding:	$27,580,000
Maximum Federal Grant Award:	$19,000,000
Minimum Federal Grant Award:
Expected Number of Awards:
Cost Sharing or Matching:	No

Applicants Eligible for this Grant: State governments - County governments - City or township governments - Special district governments - Independent school districts - Public and State controlled institutions of higher education - Native American tribal governments (Federally recognized) - Public housing authorities/Indian housing authorities - Native American tribal organizations (other than Federally recognized tribal governments) - Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education - Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education - Private institutions of higher education - For profit organizations other than small businesses - Small businesses - Others (see text field entitled "Additional Information on Eligibility" for clarification)
Additional Information on Eligibility: Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Organizations) are not eligible to apply. Foreign (non-U.S.) components of U.S. Organizations are allowed.
Link to Full Grant Announcement: Information not provided
Grant Announcement Contact: NIH OER [email protected]
If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster [[email protected]]
Similar Government Grants: • Development of Alternative Human Models of Radiation-Induced Injuries (Extracorporeal Syst...; • Discovery and Development of Novel Therapeutics for Select Fungal Pathogens (R21/R33 Clini...; • Strategies for Eliminating HIV Proteins (R21 Clinical Trial Not Allowed); • Strategies for Eliminating HIV Proteins (R01 Clinical Trial Not Allowed); • Promoting Innovative Research in Treponema pallidum Pathogenesis (R21 Clinical Trial Not A...; • Center for HIV/AIDS Vaccine Immunology (CHAVI); • Genomics of Transplantation Cooperative Research Program; • Asthma and Allergic Diseases Cooperative Research Centers
More Grants from the National Institutes of Health: • Centers on the Demography and Economics of Aging, Including Alzheimer's Disease and Alzhei...; • Development of Alternative Human Models of Radiation-Induced Injuries (Extracorporeal Syst...; • Centers for Precision Disease Modeling (U54) (Clinical Trials Not Allowed); • Centers on the Demography and Economics of Aging and Alzheimers Disease and Alzheimers Dis...; • Limited Competition: CCRP Initiative: Promoting a Basic Understanding of Chemical Threats ...